Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance loci

Antimicrob Agents Chemother. 2011 Aug;55(8):3968-9. doi: 10.1128/AAC.00332-11.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics*

Substances

  • Antitubercular Agents
  • Bacterial Proteins